Aseptic Processing of Pharmaceutical and Biotech Products Course: Fundamental Principles, Advanced Techniques, and Regulatory Insights Training (ON-DEMAND) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Aseptic Processing of Pharmaceutical and Biotech Products Course" training has been added to ResearchAndMarkets.com's offering.

This comprehensive course covers fundamental principles, advanced techniques, and regulatory insights necessary for success in aseptic processing. Explore the critical practices and regulatory requirements essential for maintaining sterility and ensuring product quality in pharmaceutical and biotech manufacturing.

To adhere to this demand and raise the benchmark of aseptic manufacturing, we have curated a 2-day long virtual course for esteemed professionals like you. Thus, if you are associated with any department of biological and pharmaceutical manufacturing, this course will upskill your knowledge about every step.

This course equips you with the knowledge to evaluate the risks and failures in the unit. Moreover, you will be able to identify the repetitive penalties being imposed on the organization due to disappointing manufacturing practices. By the end of this seminar, your products will be ready to pass sterility tests and FDA audits without any hiccups.

Course Overview

While current GMPs are detailed enough to meet FDA guidelines, many manufacturing units suffer production delays, product losses, and health risks. What is the point of working with high-end facilities and setups when you are still facing common issues?

To tackle these, World Compliance Seminar has curated a course to guide you about handling manufacturing facilities effectively. The core benefits of the aseptic processing course include:

• Managing the complexity of working with highly potent ingredients and executing fill-finish effectively
• Identifying and overcoming issues with single-use system
• Exploring the latest technologies available in aseptic filling
• Best practices to eliminate contamination risk through barrier technology
• Deeper insights from regulatory panels across the leading countries in the world
• Understanding the role of robotics in aseptic processing
• Examining strong trends in small-scale and ready-to-use products

Who Should Attend:

Aseptic sterile technique training will benefit plenty of individuals such as:

• Manufacturing professionals: Get the right knowledge of basic principles and develop skills to control procedure setting
• Project Manager: Understand critical factors required to maintain compliance
• Quality Control Professionals: Decrease the inspections failures, cautionary letters, and agreement rulings
• Reformulation and Formulation Developer: Determine how to develop media fill simulations and work on the worst-case scenarios
• Process Chemistry Specialists: Learn the best repetition techniques for decisive media fill sizes

Apart from these professionals, the course is also useful for analytical chemists, in-house regulatory compliance officials, scale-up and technology transfer professionals, and validation experts.

Key Topics Covered:

Aseptic Processing - Introduction

• The Disinfected Quantity Form
• Conservation and control of serious surroundings
• Expansion of procedures for process, standardization, Preventive Maintenance, CAPA, etc.
• Exercise of workers to include gowning
• Certification and assessment of variations
• Adulteration Sources in Sterile Manufacturing
• Subdivision Content Controls
• Cross Pollution Hazards
• Cleaning Process and Agents for Sterile Production

Developing Media Fill Requirements in An Aseptic Environment

• Form FDA 483s
• Equipment set up
• Sterilization process
• Media fills
• Smoke studies and their emphasis in Aseptic Production (ISO Class 5 facilities)
• Endotoxin sources

Speakers:

Barry A. Friedman, Ph.D

Consultant

Cambrex Bio Sciences

Dr. Friedman possesses over 30 years of industrial managerial experience in various aspects of biopharmaceuticals and medical devices to include regulatory compliance, expert witness testimony, GLP/GMP, quality control, auditing, sterility assurance, microbiological/analytical validations and fermentation technology.

Prior to becoming an independent consultant, Dr. Friedman was associated with Cambrex Bio Sciences, a contract manufacturer of GMP bulk biopharmaceuticals located in Baltimore, Maryland. As the Director of Quality Control, he managed a multi-shift Department of thirty one individuals involved in client management, the receipt and testing of raw materials, environmental monitoring and microbiology, analytical chemistry and QC compliance for the production of Phase 1, 2, 3 and commercial products manufactured from bacteria, yeast and mammalian cells. In this capacity, Dr Friedman enjoyed many client and regulatory interactions, both domestic and international.

Prior to 2000, Dr. Friedman was the Laboratory Director for Chesapeake Biological Laboratories, a contract Aseptic Fill n' Finish manufacturer located in Baltimore, Maryland. In addition to the professional history listed above, other associations have included W.R. Grace, Sigma Chemical Co., Sherwood Medical, Becton Dickinson, American Cyanamid and Union Carbide.

Dr. Friedman received his B.S. degree in Microbiology from Ohio State University, his M.S. from Michigan State University in Microbial Genetics, and his PhD from Ohio State University in Microbiology.

For more information about this training visit https://www.researchandmarkets.com/r/h4uyyq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.